Evaluation of the Recovery Rate and Postoperative Incontinence of Surgical Fistulas in a Cohort of a Reference Centre

Condition(s) studied

Investigational drug(s) / intervention(s)

pus sample: A pus sample from the fistula will be taken by the doctor during this first consultation or, failing that, in the operating room before disinfection.

Study summary

Fistula is a pathology that can be complex and lead to treatment difficulties for the proctologist.

The proctologist's objective is to treat the infection (anal fistula and abscess) with the minimum impact on anal continence. Drainage of the fistula pathway(s) and removal of infected tissue during initial surgery are essential. The treatment of upper trans-sphincterial fistulas, i. e. those that span more than half the height of the anal sphincter, poses risks to anal continence. It sometimes requires several times of surgical treatment.

The study aim to investigate the fate of all patients treated for anal fistula in an expert team, in terms of impact on healing and anal continence and according to the type of anal fistula, the co-morbidity, the surgical techniques used and the bacterial flora responsible.

Eligibility

Primary outcome measure(s)

• Healing rate at 2 years after initial surgical management of anal fistula. — 2 years
  Healing is defined by the absence of anal pain, pus discharge and anal swelling reported by the patient.

Trial sites (1)

More Groupe Hospitalier Diaconesses Croix Saint-Simon trials in France

Other trials for the same condition